Role of mTOR in the degradation of IRS-1: regulation of PP2A activity. [electronic resource]
Producer: 20020722Description: 304-14 p. digitalISSN:- 0730-2312
- 3T3 Cells -- drug effects
- Adipocytes -- metabolism
- Animals
- Antibiotics, Antineoplastic -- pharmacology
- Becaplermin
- Electrophoretic Mobility Shift Assay
- Enzyme Inhibitors -- pharmacology
- Fibroblasts -- drug effects
- Hypoglycemic Agents -- pharmacology
- Immunoblotting
- Insulin -- pharmacology
- Insulin Receptor Substrate Proteins
- Mice
- Okadaic Acid -- pharmacology
- Phosphoprotein Phosphatases -- antagonists & inhibitors
- Phosphoproteins -- genetics
- Platelet-Derived Growth Factor -- pharmacology
- Protein Kinases -- physiology
- Protein Serine-Threonine Kinases -- metabolism
- Proto-Oncogene Proteins
- Proto-Oncogene Proteins c-akt
- Proto-Oncogene Proteins c-sis
- Ribosomal Protein S6 Kinases -- metabolism
- Sirolimus -- pharmacology
- TOR Serine-Threonine Kinases
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.